Selective antagonists of A.sub.2A adenosine receptors are provided. The novel A.sub.2A blockers are useful for the treatment of Parkinson's disease and other diseases.

 
Web www.patentalert.com

< Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom

< Characterizing biological stimuli by response curves

> Pharmacological treatment of psoriasis

> Vaginal health products
~ 00227